Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer
Clinical trial NCT03588091 · COMPLETED
Trial details
- NCT number
- NCT03588091
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-24
- Primary completion
- 2024-01-31
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.